Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00837876 | Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 37 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 |
| clinicaltrials |
| NCT00679913 | Standardization of Surgery on the Pancreatic Cancer | completed | Phase 3 | 244 | Seoul National University HospitalOTHER | 1 | Jun 6, 2014 | clinicaltrials |
| NCT00968175 | Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic Cancer | completed | N/A | 60 | University of Alabama at BirminghamOTHER | 1 | Jun 4, 2014 | clinicaltrials |
| NCT00331682 | Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer | completed | Phase 2 | 10 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00002955 | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas | completed | Phase 2 | 21 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00183846 | Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers | completed | Phase 1 | 22 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00305877 | Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery | completed | Phase 2 | 137 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT00091026 | Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 143 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT00841191 | A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors | completed | Phase 1 / Phase 2 | 84 | Centocor, Inc.INDUSTRY | 5 | May 14, 2014 | clinicaltrials |
| NCT00942682 | Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors | completed | Phase 1 | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 29, 2014 | clinicaltrials |
| NCT00997958 | Study of CellCept for Advanced Pancreatic Cancer | completed | Phase 1 | 12 | Columbia UniversityOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT01020006 | Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine | completed | Phase 2 | 42 | Pharmacyclics LLC.INDUSTRY | 1 | Apr 24, 2014 | clinicaltrials |
| NCT01479803 | Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUS(PICORE) | completed | Phase 3 | 80 | VANBIERVLIETOTHER | 1 | Apr 23, 2014 | clinicaltrials |
| NCT02118077 | Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer(PC6) | completed | Phase 3 | 154 | Cancer Advances Inc.INDUSTRY | 0 | Apr 21, 2014 | clinicaltrials |
| NCT00044031 | Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma | completed | Phase 3 | 394 | Cancer Advances Inc.INDUSTRY | 0 | Apr 17, 2014 | clinicaltrials |
| NCT01124786 | A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) | completed | Phase 2 | 367 | Clovis Oncology, Inc.INDUSTRY | 15 | Apr 17, 2014 | clinicaltrials |
| NCT00203892 | Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma | completed | Phase 1 / Phase 2 | 23 | University of ChicagoOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT00582699 | Depression, Cytokines and Pancreatic Cancer | completed | — | 80 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 10, 2014 | clinicaltrials |
| NCT00980889 | RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction | completed | Phase 4 | 400 | Stockholm South General HospitalOTHER | 1 | Apr 8, 2014 | clinicaltrials |
| NCT01505413 | Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer(GEMOX-T) | completed | Phase 2 | 33 | Soonchunhyang University HospitalOTHER | 1 | Apr 3, 2014 | clinicaltrials |
| NCT02098291 | An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma(PC1) | completed | Phase 2 | 34 | Cancer Advances Inc.INDUSTRY | 0 | Mar 28, 2014 | clinicaltrials |
| NCT02098239 | Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer. | completed | Phase 2 | 41 | Cancer Advances Inc.INDUSTRY | 0 | Mar 27, 2014 | clinicaltrials |
| NCT00243854 | Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer | completed | Phase 1 | 8 | Indiana UniversityOTHER | 1 | Mar 18, 2014 | clinicaltrials |
| NCT00303758 | Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 202 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Mar 4, 2014 | clinicaltrials |
| NCT00462553 | Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT01145456 | Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT01317836 | PET-CT in Diagnosis of Pancreatic Cystic Neoplasms | completed | — | 31 | Turku University HospitalOTHER_GOV | 1 | Feb 17, 2014 | clinicaltrials |
| NCT00897741 | Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer | completed | — | 10 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT01097512 | AS703569 and Gemcitabine Combination in Advanced Malignancies | completed | Phase 1 | 66 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 2 | Jan 30, 2014 | clinicaltrials |
| NCT00910741 | NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia | completed | Phase 1 / Phase 2 | 40 | NanoCarrier Co., Ltd.INDUSTRY | 2 | Jan 9, 2014 | clinicaltrials |
| NCT00551096 | Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors | completed | Phase 1 | 23 | University of Colorado, DenverOTHER | 1 | Dec 25, 2013 | clinicaltrials |
| NCT00711191 | A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas | completed | Phase 1 | 22 | Hoffmann-La RocheINDUSTRY | 1 | Dec 24, 2013 | clinicaltrials |
| NCT01789073 | Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay | completed | N/A | 35 | University of CopenhagenOTHER | 1 | Dec 23, 2013 | clinicaltrials |
| NCT00515866 | Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer | completed | Phase 1 | 68 | AstraZenecaINDUSTRY | 2 | Dec 20, 2013 | clinicaltrials |
| NCT00058201 | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | completed | Phase 3 | 1,030 | Royal Liverpool University HospitalOTHER_GOV | 13 | Dec 18, 2013 | clinicaltrials |
| NCT00900003 | Studying Biomarkers in Patients With Pancreatic Cancer | completed | — | 53 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Dec 12, 2013 | clinicaltrials |
| NCT00003216 | Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | completed | Phase 3 | 518 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 19, 2013 | clinicaltrials |
| NCT00003591 | Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer | completed | Phase 2 | 122 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 13, 2013 | clinicaltrials |
| NCT00052689 | Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 88 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00085371 | Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | completed | Phase 2 | 116 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01945879 | Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer | completed | Phase 1 / Phase 2 | 19 | CONKO-StudiengruppeOTHER | 1 | Sep 19, 2013 | clinicaltrials |
| NCT00053222 | Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine | completed | Phase 2 | 13 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT01166490 | A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma | completed | Phase 1 | 51 | Seagen Inc.INDUSTRY | 1 | Aug 27, 2013 | clinicaltrials |
| NCT00425360 | Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | 1,110 | Royal Liverpool University HospitalOTHER_GOV | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00335543 | Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery | completed | Phase 2 | 254 | Interdisziplinare Arbeitsgruppe Gastrointestinaler Tumore der Deutschen KrebsgesellschaftOTHER | 3 | Aug 12, 2013 | clinicaltrials |
| NCT00462852 | Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 120 | Hull University Teaching Hospitals NHS TrustOTHER_GOV | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00602082 | Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors | completed | Phase 2 | 84 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Aug 7, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jun 25, 2014source: clinicaltrials